In a recent meta-analysis, researchers examined associations between antidepressant use and incidence of all-cause mortality and cardiovascular events among samples of the general public and individuals...
In a recent meta-analysis and systematic review, researchers examined prevalence of relapse and characteristics that influence relapse risk among patients with anxiety disorders who discontinued...
Depressive symptoms and elevated C-reactive protein levels are common among individuals with schizophrenia, but little is known about the relationship between these factors. In a recent study, researchers...
While higher lifetime antipsychotic exposure has been associated with poorer cognition in patients with schizophrenia, the effects of adjunctive psychiatric medication use and lifetime trends are not well...
In a recent study, researchers sought to assess the effect of hyperthermic yoga on depressive symptoms. Findings were presented at the 125th Annual Convention of the American Psychological Association. ...
In a recent study, researchers compared the safety and efficacy of 2 drugs for adults with acute exacerbations of schizophrenia. To see results of the study, including which drugs were evaluated, read...
Although substance use disorders are related to higher mortality risk among patients with attention deficit hyperactivity disorder, less information exists on the impact of ADHD medication on substance...
A recent study compared the effects of extend-release tramadol with clonidine and buprenorphine on withdrawal symptoms and retention among patients with opioid use disorder.
Schizophrenia patients taking antipsychotics face a greater risk of cardiovascular disease. In a recent study, researchers tested the effects of a glucagon-like peptide-1 receptor agonist in schizophrenia...
